Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice

Hypertension Research

Volumn 30, Issue 3, 2007, Pages 259-267

  Koga, Mitsuhisa ^a,b   Kai, Hisashi ^a   Yasukawa, Hideo ^c   Kato, Seiya ^d   Yamamoto, Tomoka ^a,b   Kawai, Yumiko ^a,b   Kusaba, Ken ^a   Seki, Yukihiko ^a   Kai, Mamiko ^b   Egashira, Kensuke ^e   Kataoka, Yusufumi ^b   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cytokine; Gene therapy; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MUTANT PROTEIN; SOLUBLE GAMMA INTERFERON RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AORTA ARCH; AORTA ROOT; AORTA WALL; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C57BL 6 MOUSE; CELL COUNT; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PLASMID; POSTNATAL CARE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMOOTH MUSCLE FIBER; UPREGULATION; WILD TYPE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHOLESTEROL, HDL; DNA; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; PERITONITIS; RECEPTORS, INTERFERON; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34247234578     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.259     Document Type: Article

References (27)

1. Ross R: Atherosclerosis: an inflammatory disease. New Engl J Med 1999; 340: 115-126.
2. Young YL, Libby P, Schonbeck U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88: 554-567.
3. Harvey EJ, Ramji DP: Interferon-γ and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res 2005; 67: 11-20.
4. Piccirillo CA, Prud'homme GJ: Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors. Hum Gene Ther 1999; 10: 1915-1922.
5. Lawson BR, Prud'homme GJ, Chang Y, et al: Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest 2000; 106: 207-215.
6. Tahara N, Kai H, Niiyama H, et al: Repeated gene transfers of naked prostacyclin synthase plasmid into skeletal muscles attenuate monocrotaline-induced pulmonary hypertension and prolong survival in rats. Hum Gene Ther 2004; 15: 1270-1278.
7. Danko I, Fritz JD, Jiao S, Hogan K, Latendresse JS, Wolff JA: Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther 1994; 1: 114-121.
8. Niiyama H, Kai H, Yamamoto T, et al: Roles of endogenous monocyte chemoattractant protein-I in ischemia-induced neovascularization. J Am Coll Cardiol 2004; 44: 661-666.
9. Molloy CJ, Taylor DS, Weber H: Angiotensin II stimulation of rapid protein tyrosin phosphorylation and protein kinase activation in rat smooth muscle cells. J Biol Chem 1993; 268: 7338-7345.
10. Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW: Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptors. Hypertension 1994; 24: 523-527.
11. Inoue S, Egashira K, Ni W, et al: Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002; 106: 2700-2706.
12. Ni W, Egashira K, Kitamoto S, et al: New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 2001; 103: 2096-2101.
13. Kuwahara F, Kai H, Tokuda K, et al: Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130-135.
14. Kai H, Mori T, Tokuda K, et al: Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 2006; 29: 711-718.
15. Vaporciyan AA, DeLisser HM, Yan HC, et al: Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993; 262: 1580-1582.
16. Yoshii T, Iwai M, Li Z, et al: Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006; 29: 457-466.
17. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFN-gamma potentiates atherosclerosis in ApoE knockout mice. J Clin Invest 1997; 99: 2752-2761.
18. Kurschner C, Ozmen L, Garotta G, Dembic Z: IFN-gamma receptor-Ig fusion proteins. Half-life, immunogenicity, and in vivo activity. J Immunol 1992; 149: 4096-4100.
19. Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G: Mouse soluble IFN gamma receptor as IFN gamma inhibitor. Distribution, antigenicity, and activity after injection in mice. J Immunol 1993; 150: 2698-2705.
20. Kurschner C, Garotta G, Dembic Z: Construction, purification, and characterization of new interferon gamma (IFN gamma) inhibitor proteins. Three IFN gamma receptor-immunoglobulin hybrid molecules. J Biol Chem 1992; 267: 9354-9360.
21. Schroder K, Hertzog PJ, Ravasi T, Hume DA: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-189.
22. Lusis AJ: Atherosclerosis. Nature 2000; 407: 233-241.
23. Charo IF, Taubaman MB: Chemokines in the pathogenesis of vascular diseases. Circ Res 2004; 95: 858-866.
24. Amento EP EN, Palmer H, Libby P: Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991; 11: 1223-1230.
25. Yuan W, Yufit T, Li L, Mori Y, Chen SJ, Varga J: Negative modulation of alphal(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma. J Cell Physiol 1999; 179: 97-108.
26. Sibinga NE, Wang H, Perrella MA, et al: Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter. J Biol Chem 1999; 274: 12139-12146.
27. Zohlnhofer D, Richter T, Neumann F, et al: Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 2001; 7: 1059-1069.